Technical Analysis for BAX - Baxter International Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
 |
82.89 | 2.68% | 2.16 |
BAX closed up 0.45 percent on Friday, August 7, 2020, on approximately normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Historical BAX trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Stochastic Buy Signal | Bullish | 2.68% | |
| Calm After Storm | Range Contraction | 2.68% | |
| NR7 | Range Contraction | 2.68% | |
| NR7-2 | Range Contraction | 2.68% | |
| Lower Bollinger Band Walk | Weakness | 2.68% | |
| Multiple of Ten Bullish | Other | 2.68% | |
| Oversold Stochastic | Weakness | 2.68% | |
| Calm After Storm | Range Contraction | 3.14% | |
| NR7 | Range Contraction | 3.14% | |
| Lower Bollinger Band Walk | Weakness | 3.14% |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 09/01/2020
- Sector: Healthcare
- Industry: Medical Instruments & Supplies
Baxter International Inc., through its subsidiaries, develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. The company operates in two segments, BioScience and Medical Products. The BioScience segment processes recombinant and plasma-based proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, alpha-1 antitrypsin deficiency, burns and shock, and other chronic and acute blood-related conditions; biosurgery products; and certain vaccines. The Medical Products segment manufactures intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, infusion pumps, and inhalation anesthetics. It also provides products and services related to pharmacy compounding, drug formulation, and packaging technologies; and to treat end-stage renal disease or irreversible kidney failure. In addition, this segment manufactures solutions and other products for peritoneal dialysis, a home-based therapy; and distributes products for hemodialysis, which is conducted in a hospital or clinic. Baxter International Inc. serves hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, clinical and medical research laboratories, and patients at home under physician supervision in the United States, Europe, the Asia-Pacific, Latin America, and Canada. The company sells its products through its direct sales force, as well as to and through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers. Baxter International Inc. was founded in 1931 and is based in Deerfield, Illinois.
Medicine Infectious Diseases Disorders Dialysis Membrane Technology Hemodialysis Nutrition Products End Stage Renal Disease Burns Hemophilia Kidney Kidney Disease Renal Dialysis Antitrypsin Deficiency Kidney Dialysis Nephrology Alpha 1 Antitrypsin Drug Wholesalers Immune Disorders Kidney Failure Peritoneal Dialysis Biosurgery Products Shock
Medicine Infectious Diseases Disorders Dialysis Membrane Technology Hemodialysis Nutrition Products End Stage Renal Disease Burns Hemophilia Kidney Kidney Disease Renal Dialysis Antitrypsin Deficiency Kidney Dialysis Nephrology Alpha 1 Antitrypsin Drug Wholesalers Immune Disorders Kidney Failure Peritoneal Dialysis Biosurgery Products Shock
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 95.19 |
| 52 Week Low | 69.1 |
| Average Volume | 3,122,303 |
| 200-Day Moving Average | 85.35 |
| 50-Day Moving Average | 86.11 |
| 20-Day Moving Average | 86.02 |
| 10-Day Moving Average | 84.75 |
| Average True Range | 2.14 |
| ADX | 20.29 |
| +DI | 20.14 |
| -DI | 38.85 |
| Chandelier Exit (Long, 3 ATRs ) | 85.03 |
| Chandelier Exit (Short, 3 ATRs ) | 85.10 |
| Upper Bollinger Band | 92.68 |
| Lower Bollinger Band | 79.36 |
| Percent B (%b) | 0.1 |
| BandWidth | 15.49 |
| MACD Line | -1.32 |
| MACD Signal Line | -0.34 |
| MACD Histogram | -0.9771 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 82.41 | ||||
| Resistance 3 (R3) | 82.35 | 81.73 | 82.13 | ||
| Resistance 2 (R2) | 81.73 | 81.30 | 81.76 | 82.04 | |
| Resistance 1 (R1) | 81.23 | 81.04 | 81.48 | 81.29 | 81.94 |
| Pivot Point | 80.61 | 80.61 | 80.74 | 80.64 | 80.61 |
| Support 1 (S1) | 80.11 | 80.18 | 80.36 | 80.17 | 79.52 |
| Support 2 (S2) | 79.49 | 79.92 | 79.52 | 79.42 | |
| Support 3 (S3) | 78.99 | 79.49 | 79.33 | ||
| Support 4 (S4) | 79.05 |
